<?xml version="1.0" encoding="UTF-8"?>
<p>IP-10 levels were determined in plasma using the CXCL10/IP-10 human Quantikine enzyme-linked immunosorbent assay (ELISA; R&amp;D Systems). Plasma from day âˆ’14 to day 40 (SIV/ZIKV cohort) and day 0 to day 40 (ZIKV cohort) were run at a 1:2 dilution in duplicate.</p>
